← FDA Drug Approvals (Drugs@FDA)

BRIVARACETAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2022-10-03

Drug application

FDA Application #

ANDA214501

Application type

Abbreviated New Drug Application (Generic)

Brand name

BRIVARACETAM

Generic name

BRIVARACETAM

Active ingredients

BRIVARACETAM

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

ZYDUS PHARMS

Manufacturer

Zydus Pharmaceuticals USA Inc.

First approval

2022-10-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown